| Year |
Citation |
Score |
| 2020 |
Meilandt WJ, Ngu H, Gogineni A, Lalehzadeh G, Lee SH, Srinivasan K, Imperio J, Wu T, Weber M, Kruse AJ, Stark KL, Chan P, Kwong M, Modrusan Z, Friedman BA, et al. Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the Aβ42:Aβ40 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer's mouse model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31980586 DOI: 10.1523/Jneurosci.1871-19.2019 |
0.327 |
|
| 2015 |
Patel S, Cohen F, Dean BJ, De La Torre K, Deshmukh G, Estrada AA, Ghosh AS, Gibbons P, Gustafson A, Huestis MP, Le Pichon CE, Lin H, Liu W, Liu X, Liu Y, ... ... Stark KL, et al. Discovery of dual leucine zipper kinase (DLK, MAP3K12) inhibitors with activity in neurodegeneration models. Journal of Medicinal Chemistry. 58: 401-18. PMID 25341110 DOI: 10.1021/Jm5013984 |
0.533 |
|
| 2013 |
Xu B, Hsu PK, Stark KL, Karayiorgou M, Gogos JA. Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion. Cell. 152: 262-75. PMID 23332760 DOI: 10.1016/J.Cell.2012.11.052 |
0.332 |
|
| 2011 |
Drew LJ, Stark KL, Fénelon K, Karayiorgou M, Macdermott AB, Gogos JA. Evidence for altered hippocampal function in a mouse model of the human 22q11.2 microdeletion. Molecular and Cellular Neurosciences. 47: 293-305. PMID 21635953 DOI: 10.1016/J.Mcn.2011.05.008 |
0.354 |
|
| 2010 |
Sigurdsson T, Stark KL, Karayiorgou M, Gogos JA, Gordon JA. Impaired hippocampal-prefrontal synchrony in a genetic mouse model of schizophrenia. Nature. 464: 763-7. PMID 20360742 DOI: 10.1038/Nature08855 |
0.491 |
|
| 2009 |
Stark KL, Burt RA, Gogos JA, Karayiorgou M. Analysis of prepulse inhibition in mouse lines overexpressing 22q11.2 orthologues. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 983-9. PMID 19519974 DOI: 10.1017/S1461145709000492 |
0.37 |
|
| 2008 |
Mukai J, Dhilla A, Drew LJ, Stark KL, Cao L, MacDermott AB, Karayiorgou M, Gogos JA. Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion. Nature Neuroscience. 11: 1302-10. PMID 18836441 DOI: 10.1038/Nn.2204 |
0.352 |
|
| 2007 |
Stark KL, Gross C, Richardson-Jones J, Zhuang X, Hen R. A novel conditional knockout strategy applied to serotonin receptors. Handbook of Experimental Pharmacology. 347-63. PMID 17203662 DOI: 10.1007/978-3-540-35109-2_14 |
0.63 |
|
| 2002 |
Bonaventure P, Nepomuceno D, Kwok A, Chai W, Langlois X, Hen R, Stark K, Carruthers N, Lovenberg TW. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice. The Journal of Pharmacology and Experimental Therapeutics. 302: 240-8. PMID 12065723 DOI: 10.1124/Jpet.302.1.240 |
0.595 |
|
| 2002 |
Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R. Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature. 416: 396-400. PMID 11919622 DOI: 10.1038/416396A |
0.696 |
|
| 2000 |
Dulawa SC, Gross C, Stark KL, Hen R, Geyer MA. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 22: 650-9. PMID 10788764 DOI: 10.1016/S0893-133X(99)00164-5 |
0.632 |
|
| 1999 |
Stark KL, Hen R. Knockout Corner. The International Journal of Neuropsychopharmacology. 2: 145-150. PMID 11281982 DOI: 10.1017/S146114579900142X |
0.68 |
|
| 1999 |
Ghavami A, Stark KL, Jareb M, Ramboz S, Ségu L, Hen R. Differential addressing of 5-HT1A and 5-HT1B receptors in epithelial cells and neurons. Journal of Cell Science. 112: 967-76. PMID 10036246 |
0.572 |
|
| 1999 |
Stark KL, Hen R. Knockout Corner 5-HT1B receptor knockout mice: A review International Journal of Neuropsychopharmacology. 2: 145-150. |
0.655 |
|
| 1998 |
Stark KL, Oosting RS, Hen R. Inducible knockout strategies to probe the functions of 5-HT receptors. Annals of the New York Academy of Sciences. 861: 57-66. PMID 9928239 DOI: 10.1111/J.1749-6632.1998.Tb10173.X |
0.589 |
|
| 1998 |
Stark KL, Oosting RS, Hen R. Novel strategies to probe the functions of serotonin receptors. Biological Psychiatry. 44: 163-8. PMID 9693388 DOI: 10.1016/S0006-3223(98)00040-7 |
0.568 |
|
| 1998 |
Oosting RS, Stark KL, Hen R, van Scharrenburg GJM. New animal models in target discovery Pharmacochemistry Library. 29: 203-213. DOI: 10.1016/S0165-7208(98)80058-5 |
0.447 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2013 |
Fénelon K, Xu B, Lai CS, Mukai J, Markx S, Stark KL, Hsu PK, Gan WB, Fischbach GD, MacDermott AB, Karayiorgou M, Gogos JA. The pattern of cortical dysfunction in a mouse model of a schizophrenia-related microdeletion. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 14825-39. PMID 24027283 DOI: 10.1523/Jneurosci.1611-13.2013 |
0.288 |
|
| 1998 |
Stark KL. Agrp, a novel gene implicated in the control of feeding. Expert Opinion On Investigational Drugs. 7: 859-64. PMID 15992003 DOI: 10.1517/13543784.7.6.859 |
0.283 |
|
| 2003 |
Arasasingham PN, Fotsch C, Ouyang X, Norman MH, Kelly MG, Stark KL, Karbon B, Hale C, Baumgartner JW, Zambrano M, Cheetham J, Tamayo NA. Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: antagonists for the AGRP/melanocortin receptor binding. Journal of Medicinal Chemistry. 46: 9-11. PMID 12502354 DOI: 10.1021/jm0255522 |
0.282 |
|
| 1998 |
Rosenfeld RD, Zeni L, Welcher AA, Narhi LO, Hale C, Marasco J, Delaney J, Gleason T, Philo JS, Katta V, Hui J, Baumgartner J, Graham M, Stark KL, Karbon W. Biochemical, biophysical, and pharmacological characterization of bacterially expressed human agouti-related protein. Biochemistry. 37: 16041-52. PMID 9819197 DOI: 10.1021/bi981027m |
0.269 |
|
| 2008 |
Stark KL, Xu B, Bagchi A, Lai WS, Liu H, Hsu R, Wan X, Pavlidis P, Mills AA, Karayiorgou M, Gogos JA. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nature Genetics. 40: 751-60. PMID 18469815 DOI: 10.1038/Ng.138 |
0.255 |
|
| 2000 |
Krebs LT, Xue Y, Norton CR, Shutter JR, Maguire M, Sundberg JP, Gallahan D, Closson V, Kitajewski J, Callahan R, Smith GH, Stark KL, Gridley T. Notch signaling is essential for vascular morphogenesis in mice. Genes & Development. 14: 1343-52. PMID 10837027 |
0.25 |
|
| 1997 |
Perkins CP, Mar V, Shutter JR, del Castillo J, Danilenko DM, Medlock ES, Ponting IL, Graham M, Stark KL, Zuo Y, Cunningham JM, Bosselman RA. Anemia and perinatal death result from loss of the murine ecotropic retrovirus receptor mCAT-1. Genes & Development. 11: 914-25. PMID 9106662 |
0.247 |
|
| 2011 |
Drew LJ, Crabtree GW, Markx S, Stark KL, Chaverneff F, Xu B, Mukai J, Fenelon K, Hsu PK, Gogos JA, Karayiorgou M. The 22q11.2 microdeletion: fifteen years of insights into the genetic and neural complexity of psychiatric disorders. International Journal of Developmental Neuroscience : the Official Journal of the International Society For Developmental Neuroscience. 29: 259-81. PMID 20920576 DOI: 10.1016/J.Ijdevneu.2010.09.007 |
0.246 |
|
| 1997 |
Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL. Overexpression of Agrt leads to obesity in transgenic mice. Nature Genetics. 17: 273-4. PMID 9354787 DOI: 10.1038/ng1197-273 |
0.21 |
|
| 1998 |
Khrebtukova I, Michaud EJ, Foster CM, Stark KL, Garfinkel DJ, Woychik RP. Utilization of microhomologous recombination in yeast to generate targeting constructs for mammalian genes. Mutation Research. 401: 11-25. PMID 9639665 DOI: 10.1016/S0027-5107(98)00053-0 |
0.208 |
|
| 1997 |
Shutter JR, Graham M, Kinsey AC, Scully S, Lüthy R, Stark KL. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes & Development. 11: 593-602. PMID 9119224 |
0.205 |
|
| 2000 |
Shutter JR, Scully S, Fan W, Richards WG, Kitajewski J, Deblandre GA, Kintner CR, Stark KL. Dll4, a novel Notch ligand expressed in arterial endothelium. Genes & Development. 14: 1313-8. PMID 10837024 |
0.204 |
|
| 1991 |
Stark KL, McMahon JA, McMahon AP. FGFR-4, a new member of the fibroblast growth factor receptor family, expressed in the definitive endoderm and skeletal muscle lineages of the mouse. Development (Cambridge, England). 113: 641-51. PMID 1723680 |
0.182 |
|
| 2021 |
Brendza R, Lin H, Stark K, Foreman O, Tao J, Pierce A, Ngu H, Shen K, Easton AE, Bhangale T, Chang D, Bingol B, Friedman BA. Genetic ablation of Gpnmb does not alter synuclein-related pathology. Neurobiology of Disease. 105494. PMID 34464706 DOI: 10.1016/j.nbd.2021.105494 |
0.158 |
|
| 2020 |
Reese RM, Dourado M, Anderson K, Warming S, Stark KL, Balestrini A, Suto E, Lee W, Riol-Blanco L, Shields SD, Hackos DH. Behavioral characterization of a CRISPR-generated TRPA1 knockout rat in models of pain, itch, and asthma. Scientific Reports. 10: 979. PMID 31969645 DOI: 10.1038/s41598-020-57936-5 |
0.157 |
|
| 1994 |
Takada S, Stark KL, Shea MJ, Vassileva G, McMahon JA, McMahon AP. Wnt-3a regulates somite and tailbud formation in the mouse embryo. Genes & Development. 8: 174-89. PMID 8299937 DOI: 10.1101/Gad.8.2.174 |
0.156 |
|
| 1999 |
Khrebtukova I, Michaud EJ, Foster CM, Stark KL, Garfinkel DJ, Woychik RP. Corrigendum to: 'Utilization of microhomologous recombination in yeast to generate targeting constructs for mammalian genes' Mutation Research. 423: 191. PMID 10029697 |
0.138 |
|
| 2023 |
Wang Y, Wu T, Tsai MC, Rezzonico MG, Abdel-Haleem AM, Xie L, Gandham VD, Ngu H, Stark K, Glock C, Xu D, Foreman O, Friedman BA, Sheng M, Hanson JE. TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice. Elife. 12. PMID 37555828 DOI: 10.7554/eLife.83451 |
0.138 |
|
| 2023 |
Deng L, Dourado M, Reese RM, Huang K, Shields SD, Stark KL, Maksymetz J, Lin H, Kaminker JS, Jung M, Foreman O, Tao J, Ngu H, Joseph V, Roose-Girma M, et al. Nav1.7 is essential for nociceptor action potentials in the mouse in a manner independent of endogenous opioids. Neuron. PMID 37352856 DOI: 10.1016/j.neuron.2023.05.024 |
0.138 |
|
| 2004 |
Krebs LT, Shutter JR, Tanigaki K, Honjo T, Stark KL, Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes & Development. 18: 2469-73. PMID 15466160 DOI: 10.1101/Gad.1239204 |
0.111 |
|
| 1991 |
Juchau MR, Harris C, Stark KL, Lee QP, Yang HY, Namkung MJ, Fantel AG. Cytochrome P450-dependent bioactivation of prodysmorphogens in cultured conceptuses. Reproductive Toxicology (Elmsford, N.Y.). 5: 259-63. PMID 1807561 DOI: 10.1016/0890-6238(91)90060-S |
0.111 |
|
| 2021 |
Lee SH, Meilandt WJ, Xie L, Gandham VD, Ngu H, Barck KH, Rezzonico MG, Imperio J, Lalehzadeh G, Huntley MA, Stark KL, Foreman O, Carano RAD, Friedman BA, Sheng M, et al. Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology. Neuron. PMID 33675684 DOI: 10.1016/j.neuron.2021.02.010 |
0.11 |
|
| 2021 |
Stark K, Goncharov T, Varfolomeev E, Xie L, Ngu H, Peng I, Anderson KR, Verschueren E, Choi M, Kirkpatrick DS, Easton A, Webster JD, McKenzie BS, Vucic D, Bingol B. Genetic inactivation of RIP1 kinase activity in rats protects against ischemic brain injury. Cell Death & Disease. 12: 379. PMID 33828080 DOI: 10.1038/s41419-021-03651-6 |
0.105 |
|
| 1999 |
Khrebtukova I, Michaud EJ, Foster CM, Stark KL, Garfinkel DJ, Woychik RP. Corrigendum: Utilization of microhomologous recombination in yeast to generate targeting constructs for mammalian genes (Mutation Research (1998) 401 (11-25) PII: S0027510798000530) Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 423: 191. DOI: 10.1016/S0027-5107(98)00200-0 |
0.098 |
|
| 1990 |
Stark KL, Lee QP, Namkung MJ, Harris C, Juchau MR. Dysmorphogenesis elicited by microinjected acetaminophen analogs and metabolites in rat embryos cultured in vitro. The Journal of Pharmacology and Experimental Therapeutics. 255: 74-82. PMID 2213573 |
0.097 |
|
| 1989 |
Stark KL, Harris C, Juchau MR. Modulation of the embryotoxicity and cytotoxicity elicited by 7-hydroxy-2-acetylaminofluorene and acetaminophen via deacetylation. Toxicology and Applied Pharmacology. 97: 548-60. PMID 2609350 DOI: 10.1016/0041-008X(89)90260-3 |
0.095 |
|
| 2022 |
Brendza R, Gao X, Stark KL, Lin H, Lee SH, Hu C, Cai H, DiCara D, Hsiao YC, Ngu H, Foreman O, Baca M, Dohse M, Fortin JP, Corpuz R, et al. Anti-α-synuclein c-terminal antibodies block PFF uptake and accumulation of phospho-synuclein in preclinical models of Parkinson's disease. Neurobiology of Disease. 105969. PMID 36535551 DOI: 10.1016/j.nbd.2022.105969 |
0.085 |
|
| 1988 |
Juchau MR, Stark KL. Mechanisms in chemical teratogenesis Isi Atlas of Science: Pharmacology. 2: 283-286. |
0.083 |
|
| 1989 |
Beyer BK, Stark KL, Fantel AG, Juchau MR. Biotransformation, estrogenicity, and steroid structure as determinants of dysmorphogenic and generalized embryotoxic effects of steroidal and nonsteroidal estrogens. Toxicology and Applied Pharmacology. 98: 113-27. PMID 2929019 DOI: 10.1016/0041-008X(89)90139-7 |
0.079 |
|
| 1989 |
Stark KL, Harris C, Juchau MR. Influence of electrophilic character and glutathione depletion on chemical dysmorphogenesis in cultured rat embryos. Biochemical Pharmacology. 38: 2685-92. PMID 2764988 DOI: 10.1016/0006-2952(89)90555-8 |
0.078 |
|
| 1989 |
Harris C, Stark KL, Luchtel DL, Juchau MR. Abnormal neurulation induced by 7-hydroxy-2-acetylaminofluorene and acetaminophen: evidence for catechol metabolites as proximate dysmorphogens. Toxicology and Applied Pharmacology. 101: 432-46. PMID 2603160 DOI: 10.1016/0041-008X(89)90192-0 |
0.078 |
|
| 1988 |
Harris C, Stark KL, Juchau MR. Glutathione status and the incidence of neural tube defects elicited by direct acting teratogens in vitro. Teratology. 37: 577-90. PMID 3135633 DOI: 10.1002/Tera.1420370607 |
0.072 |
|
| 1987 |
Stark KL, Harris C, Juchau MR. Embryotoxicity elicited by inhibition of gamma-glutamyltransferase by Acivicin and transferase antibodies in cultured rat embryos. Toxicology and Applied Pharmacology. 89: 88-96. PMID 2884755 DOI: 10.1016/0041-008X(87)90179-7 |
0.068 |
|
| 2006 |
Franklin RC, Stark KL, Fragar L. Intervention strategies for the retro-fitment of Rollover Protective Structures (ROPS) and fleet characteristic, farm tractors Safety Science. 44: 771-783. DOI: 10.1016/j.ssci.2006.04.002 |
0.063 |
|
| 1989 |
Stark KL, Juchau MR. Microinjection of cultured rat embryos: a new technique for studies in chemical dysmorphogenesis. Toxicology and Applied Pharmacology. 100: 411-6. PMID 2781566 DOI: 10.1016/0041-008X(89)90289-5 |
0.062 |
|
| 2003 |
Miura GI, Froelick GJ, Marsh DJ, Stark KL, Palmiter RD. The d subunit of the vacuolar ATPase (Atp6d) is essential for embryonic development. Transgenic Research. 12: 131-3. PMID 12650533 DOI: 10.1023/A:1022118627058 |
0.05 |
|
| 1998 |
Bures EJ, Hui JO, Young Y, Chow DT, Katta V, Rohde MF, Zeni L, Rosenfeld RD, Stark KL, Haniu M. Determination of disulfide structure in agouti-related protein (AGRP) by stepwise reduction and alkylation. Biochemistry. 37: 12172-7. PMID 9724530 DOI: 10.1021/bi981082v |
0.044 |
|
| 1986 |
Fox MJ, Simlote VN, Stark KL, Brinlee LD. REVIEW OF CO//2 FLOOD, SPRINGER 'A' SAND, NE PURDY UNIT, GARVIN COUNTY, OKLAHOMA Society of Petroleum Engineers of Aime, (Paper) Spe. 2: 185-198. |
0.04 |
|
| 1994 |
Hill WJ, Tinney TJ, Young LC, Stark KL. CO2 operating plan, South Welch unit, Dawson County, Texas Proceedings of the Permian Basin Oil & Gas Recovery Conference. 493-504. |
0.03 |
|
| 1999 |
Young Y, Zeni L, Rosenfeld RD, Stark KL, Rohde MF, Haniu M. Disulfide assignment of the C-terminal cysteine knot of agouti-related protein (AGRP) by direct sequencing analysis. The Journal of Peptide Research : Official Journal of the American Peptide Society. 54: 514-21. PMID 10604596 DOI: 10.1034/j.1399-3011.1999.00126.x |
0.03 |
|
| 2000 |
Stark KL, Gibson JB, Hertle RW, Brodsky MC. Ocular motor signs in an infant with carbohydrate-deficient glycoprotein syndrome type Ia. American Journal of Ophthalmology. 130: 533-5. PMID 11024435 DOI: 10.1016/S0002-9394(00)00569-9 |
0.023 |
|
| 1999 |
Stark KL, Kaufman B, Lee BC, Primack J, Tychsen L. Visual recovery after a year of craniopharyngioma-related amaurosis: report of a nine-year-old child and a review of pathophysiologic mechanisms. Journal of Aapos : the Official Publication of the American Association For Pediatric Ophthalmology and Strabismus / American Association For Pediatric Ophthalmology and Strabismus. 3: 366-71. PMID 10613582 |
0.019 |
|
| Hide low-probability matches. |